Patent · US Active

Modified EL188 endolysin sequence

US10167462B2 · kind B2 · utility

0Cited by
1References
19Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 14, 2014
Grant dateJan 1, 2019
Priority date
Expiry dateDec 14, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to polypeptides comprising an amino acid sequence exhibiting at least about 90% sequence identity with the sequence of SEQ ID NO: 1. Said polypeptides preferably degrade the peptidoglycan of Gram-negative bacteria, in particular of Pseudomonas and/or Campylobacter bacteria. In addition, the present invention relates to nucleic acids encoding such polypeptides, vectors comprising such nucleic acids, and corresponding host cells. Finally, the present invention relates to compositions comprising such polypeptides, nucleic acids, vectors, and/or host cells according to the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.